
Vijay Shankar
Examiner (ID: 12272, Phone: (571)272-7682 , Office: P/2697 )
| Most Active Art Unit | 2624 |
| Art Unit(s) | 2614, 2624, 2673, 2777, 2607, 2629, 2622, 2697, 2778, 2605, 2775, 2787, 2743 |
| Total Applications | 2665 |
| Issued Applications | 2187 |
| Pending Applications | 287 |
| Abandoned Applications | 215 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14291849
[patent_doc_number] => 10286032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Pro-angiogenic fragments of prominin-1 and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/745562
[patent_app_country] => US
[patent_app_date] => 2015-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 22
[patent_no_of_words] => 34996
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14745562
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/745562 | Pro-angiogenic fragments of prominin-1 and uses thereof | Jun 21, 2015 | Issued |
Array
(
[id] => 10458075
[patent_doc_number] => 20150343090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'INTRACELLULAR DELIVERY SYSTEM AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/727373
[patent_app_country] => US
[patent_app_date] => 2015-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 24194
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14727373
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/727373 | INTRACELLULAR DELIVERY SYSTEM AND METHODS | May 31, 2015 | Abandoned |
Array
(
[id] => 11462702
[patent_doc_number] => 09579317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-28
[patent_title] => 'Peptide-drug conjugates'
[patent_app_type] => utility
[patent_app_number] => 14/726897
[patent_app_country] => US
[patent_app_date] => 2015-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8493
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14726897
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/726897 | Peptide-drug conjugates | May 31, 2015 | Issued |
Array
(
[id] => 15393963
[patent_doc_number] => 10537618
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Prohemostatic proteins for the treatment of bleeding
[patent_app_type] => utility
[patent_app_number] => 15/313881
[patent_app_country] => US
[patent_app_date] => 2015-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 25
[patent_no_of_words] => 13572
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313881
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/313881 | Prohemostatic proteins for the treatment of bleeding | May 25, 2015 | Issued |
Array
(
[id] => 10482011
[patent_doc_number] => 20150367028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'AMPHIPHILIC LINEAR PEPTIDE/PEPTOID AND HYDROGEL COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/719674
[patent_app_country] => US
[patent_app_date] => 2015-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 18429
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14719674
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/719674 | Amphiphilic linear peptide/peptoid and hydrogel comprising the same | May 21, 2015 | Issued |
Array
(
[id] => 10663634
[patent_doc_number] => 20160009778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'INSULIN LIKE PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/711494
[patent_app_country] => US
[patent_app_date] => 2015-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6848
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14711494
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/711494 | Insulin like peptides | May 12, 2015 | Issued |
Array
(
[id] => 10361133
[patent_doc_number] => 20150246136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'NOVEL BINDER-DRUG CONJUGATES (ADCs) AND USE OF SAME'
[patent_app_type] => utility
[patent_app_number] => 14/708914
[patent_app_country] => US
[patent_app_date] => 2015-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 149074
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14708914
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/708914 | NOVEL BINDER-DRUG CONJUGATES (ADCs) AND USE OF SAME | May 10, 2015 | Abandoned |
Array
(
[id] => 11455942
[patent_doc_number] => 20170049848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'Target for Firmicutes and Related Bacteria: The PRP Protease'
[patent_app_type] => utility
[patent_app_number] => 15/308455
[patent_app_country] => US
[patent_app_date] => 2015-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 31484
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308455
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/308455 | Target for Firmicutes and Related Bacteria: The PRP Protease | May 5, 2015 | Abandoned |
Array
(
[id] => 10339076
[patent_doc_number] => 20150224081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'COMPOSITION AND METHOD FOR TREATMENT OF DIABETES'
[patent_app_type] => utility
[patent_app_number] => 14/695439
[patent_app_country] => US
[patent_app_date] => 2015-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6346
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14695439
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/695439 | COMPOSITION AND METHOD FOR TREATMENT OF DIABETES | Apr 23, 2015 | Abandoned |
Array
(
[id] => 10435700
[patent_doc_number] => 20150320712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'Nutritional Composition for Gastrostomy-Tube Patients'
[patent_app_type] => utility
[patent_app_number] => 14/688163
[patent_app_country] => US
[patent_app_date] => 2015-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16429
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14688163
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/688163 | Nutritional Composition for Gastrostomy-Tube Patients | Apr 15, 2015 | Abandoned |
Array
(
[id] => 15227627
[patent_doc_number] => 10501524
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Albumin variants
[patent_app_type] => utility
[patent_app_number] => 14/685112
[patent_app_country] => US
[patent_app_date] => 2015-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 4
[patent_no_of_words] => 37986
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14685112
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/685112 | Albumin variants | Apr 12, 2015 | Issued |
Array
(
[id] => 14420249
[patent_doc_number] => 10314911
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Methods for protecting and treating traumatic brain injury, concussion and brain inflammation with intranasal insulin
[patent_app_type] => utility
[patent_app_number] => 14/679667
[patent_app_country] => US
[patent_app_date] => 2015-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 8928
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14679667
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/679667 | Methods for protecting and treating traumatic brain injury, concussion and brain inflammation with intranasal insulin | Apr 5, 2015 | Issued |
Array
(
[id] => 10712726
[patent_doc_number] => 20160058873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'Cyclodextrin-Based Polymers for Therapeutic Delivery'
[patent_app_type] => utility
[patent_app_number] => 14/665301
[patent_app_country] => US
[patent_app_date] => 2015-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 60617
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14665301
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/665301 | Cyclodextrin-Based Polymers for Therapeutic Delivery | Mar 22, 2015 | Abandoned |
Array
(
[id] => 10435896
[patent_doc_number] => 20150320908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'BUILDING STRATIFIED BIOMIMETIC TISSUES AND ORGANS USING CROSSLINKED ULTRASHORT PEPTIDE HYDROGEL MEMBRANES'
[patent_app_type] => utility
[patent_app_number] => 14/639035
[patent_app_country] => US
[patent_app_date] => 2015-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 61
[patent_no_of_words] => 33344
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14639035
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/639035 | Building stratified biomimetic tissues and organs using crosslinked ultrashort peptide hydrogel membranes | Mar 3, 2015 | Issued |
Array
(
[id] => 12253176
[patent_doc_number] => 09925307
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Crosslinked peptide hydrogels'
[patent_app_type] => utility
[patent_app_number] => 14/634559
[patent_app_country] => US
[patent_app_date] => 2015-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 73
[patent_no_of_words] => 28378
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14634559
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/634559 | Crosslinked peptide hydrogels | Feb 26, 2015 | Issued |
Array
(
[id] => 12253176
[patent_doc_number] => 09925307
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Crosslinked peptide hydrogels'
[patent_app_type] => utility
[patent_app_number] => 14/634559
[patent_app_country] => US
[patent_app_date] => 2015-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 73
[patent_no_of_words] => 28378
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14634559
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/634559 | Crosslinked peptide hydrogels | Feb 26, 2015 | Issued |
Array
(
[id] => 12253176
[patent_doc_number] => 09925307
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Crosslinked peptide hydrogels'
[patent_app_type] => utility
[patent_app_number] => 14/634559
[patent_app_country] => US
[patent_app_date] => 2015-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 73
[patent_no_of_words] => 28378
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14634559
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/634559 | Crosslinked peptide hydrogels | Feb 26, 2015 | Issued |
Array
(
[id] => 12253176
[patent_doc_number] => 09925307
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Crosslinked peptide hydrogels'
[patent_app_type] => utility
[patent_app_number] => 14/634559
[patent_app_country] => US
[patent_app_date] => 2015-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 73
[patent_no_of_words] => 28378
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14634559
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/634559 | Crosslinked peptide hydrogels | Feb 26, 2015 | Issued |
Array
(
[id] => 10346205
[patent_doc_number] => 20150231210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'Pharmaceutical Composition for Treating a Metabolic Syndrome'
[patent_app_type] => utility
[patent_app_number] => 14/628037
[patent_app_country] => US
[patent_app_date] => 2015-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5721
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14628037
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/628037 | Pharmaceutical Composition for Treating a Metabolic Syndrome | Feb 19, 2015 | Abandoned |
Array
(
[id] => 10325741
[patent_doc_number] => 20150210745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'Double-Acylated GLP-1 Derivatives with a Linker'
[patent_app_type] => utility
[patent_app_number] => 14/608284
[patent_app_country] => US
[patent_app_date] => 2015-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41281
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14608284
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/608284 | Double-Acylated GLP-1 Derivatives with a Linker | Jan 28, 2015 |